Adverse event reporting and Bell's palsy risk after COVID-19 vaccination.

Khouri, Charles; Roustit, Matthieu; Cracowski, Jean-Luc

Khouri, Charles; Roustit, Matthieu; Cracowski, Jean-Luc.

Khouri C; Pharmacovigilance Department, Grenoble Alpes University, Grenoble, F-38000 France; Clinical Pharmacology Department, INSERM CIC1406, Grenoble Alpes University, Grenoble, F-38000 France; INSERM UMR 1300-Laboratory HP2, Grenoble Alpes University, Grenoble, F-38000 France; Centre Regional de Pharmacovigilance, CHU Grenoble Alpes, CS 10217, 38043 Grenoble Cedex 9, France. Electronic address: ckhouri@chu-grenoble.fr.
Roustit M; Clinical Pharmacology Department, INSERM CIC1406, Grenoble Alpes University, Grenoble, F-38000 France; INSERM UMR 1300-Laboratory HP2, Grenoble Alpes University, Grenoble, F-38000 France.
Cracowski JL; Pharmacovigilance Department, Grenoble Alpes University, Grenoble, F-38000 France; INSERM UMR 1300-Laboratory HP2, Grenoble Alpes University, Grenoble, F-38000 France.

Lancet Infect Dis ; 21(11): 1490-1491, 2021 11.

Article in English | MEDLINE | ID: covidwho-1492856

Subject(s)

Bell Palsy; COVID-19; Bell Palsy/epidemiology; Bell Palsy/etiology; COVID-19 Vaccines; Humans; SARS-CoV-2; Vaccination/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Bell Palsy / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google